https://www.selleckchem.com/products/abt-199.html
Major complications within 30 days occurred more frequently in AVNA patients than non-AVNA patients (7.3% vs. 2.0%, p .001). The risk of major complications through 36-months was higher in AVNA patients (hazard ratio 3.81, 95% confidence interval 2.33-6.23, p .001). Intermittent loss of capture occurred in three AVNA patients (1.6%), all were within 30 days of implant and required system revision. There were no device macrodislodgements or unexpected device malfunctions. Concomitant AVN ablation and leadless pacemaker implant
Kao
Komentar
Udio
